132 related articles for article (PubMed ID: 11745890)
1. Bone mass after treatment of malignant lymphoma in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
Med Pediatr Oncol; 2001 Dec; 37(6):518-24. PubMed ID: 11745890
[TBL] [Abstract][Full Text] [Related]
2. Degree of fatness after treatment of malignant lymphoma in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
Med Pediatr Oncol; 2003 Apr; 40(4):239-43. PubMed ID: 12555252
[TBL] [Abstract][Full Text] [Related]
3. Bone mass after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Oncol; 1998 Dec; 16(12):3752-60. PubMed ID: 9850018
[TBL] [Abstract][Full Text] [Related]
4. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in pediatric survivors of Hodgkin and non-Hodgkin lymphomas.
Muszynska-Roslan K; Latoch E; Konstantynowicz J; Panasiuk A; Stewart A; Krawczuk-Rybak M
Adv Med Sci; 2014 Sep; 59(2):200-5. PubMed ID: 25323758
[TBL] [Abstract][Full Text] [Related]
6. Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphoma.
van Waas M; Neggers SJ; Te Winkel ML; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
Ann Oncol; 2012 Jun; 23(6):1626-32. PubMed ID: 22048153
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
van Beek RD; van den Heuvel-Eibrink MM; Hakvoort-Cammel FG; van den Bos C; van der Pal HJ; Krenning EP; de Rijke YB; Pieters R; de Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 2009 Jun; 94(6):1904-9. PubMed ID: 19293271
[TBL] [Abstract][Full Text] [Related]
8. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma.
Nysom K; Holm K; Michaelsen KF; Hertz H; Jacobsen N; Müller J; Mølgaard C
Bone Marrow Transplant; 2000 Jan; 25(2):191-6. PubMed ID: 10673679
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral status after treatment of malignant lymphoma in childhood and adolescence.
Sala A; Talsma D; Webber C; Posgate S; Atkinson S; Barr R
Eur J Cancer Care (Engl); 2007 Jul; 16(4):373-9. PubMed ID: 17587363
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood.
Benmiloud S; Steffens M; Beauloye V; de Wandeleer A; Devogelaer JP; Brichard B; Vermylen C; Maiter D
Horm Res Paediatr; 2010; 74(4):241-250. PubMed ID: 20395671
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
[TBL] [Abstract][Full Text] [Related]
13. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
[TBL] [Abstract][Full Text] [Related]
15. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
16. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Łuczyński W; Kaczmarski M; Wołczynski S; Piotrowska-Jastrzebska J
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1041-54. PubMed ID: 15951599
[TBL] [Abstract][Full Text] [Related]
17. Bone mass and body composition after cessation of therapy for childhood cancer.
Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
[TBL] [Abstract][Full Text] [Related]
18. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
19. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation.
Seland M; Smeland KB; Bjøro T; Falk RS; Fosså SD; Gjesdal CG; Godang K; Holte H; Svartberg J; Syversen U; Bollerslev J; Kiserud CE
Acta Oncol; 2017 Apr; 56(4):590-598. PubMed ID: 28077016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
